A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 134,834 shares of IDXX stock, worth $56.2 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
134,834
Previous 139,207 3.14%
Holding current value
$56.2 Million
Previous $67.8 Million 0.4%
% of portfolio
0.62%
Previous 0.65%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$455.08 - $517.19 $1.99 Million - $2.26 Million
-4,373 Reduced 3.14%
134,834 $68.1 Million
Q2 2024

Jul 17, 2024

SELL
$468.04 - $548.53 $500,802 - $586,927
-1,070 Reduced 0.76%
139,207 $67.8 Million
Q1 2024

Apr 23, 2024

SELL
$515.08 - $576.87 $784,466 - $878,573
-1,523 Reduced 1.07%
140,277 $75.7 Million
Q4 2023

Feb 01, 2024

SELL
$391.37 - $557.56 $3.35 Million - $4.77 Million
-8,564 Reduced 5.7%
141,800 $78.7 Million
Q3 2023

Nov 03, 2023

SELL
$432.42 - $556.67 $1.84 Million - $2.37 Million
-4,253 Reduced 2.75%
150,364 $65.7 Million
Q2 2023

Aug 01, 2023

SELL
$450.7 - $503.61 $44,619 - $49,857
-99 Reduced 0.06%
154,617 $77.7 Million
Q1 2023

May 02, 2023

BUY
$406.01 - $514.59 $430,370 - $545,465
1,060 Added 0.69%
154,716 $77.4 Million
Q4 2022

Mar 02, 2023

BUY
$324.64 - $441.27 $327,886 - $445,682
1,010 Added 0.66%
153,656 $62.7 Million
Q4 2022

Feb 14, 2023

SELL
$324.64 - $441.27 $140,569 - $191,069
-433 Reduced 0.28%
152,646 $75.7 Million
Q3 2022

Oct 25, 2022

BUY
$325.8 - $407.78 $129,668 - $162,296
398 Added 0.26%
153,079 $49.9 Million
Q2 2022

Jul 26, 2022

BUY
$327.37 - $553.44 $177,434 - $299,964
542 Added 0.36%
152,681 $53.5 Million
Q1 2022

Apr 13, 2022

SELL
$466.52 - $631.01 $112,431 - $152,073
-241 Reduced 0.16%
152,139 $83.2 Million
Q4 2021

Feb 14, 2022

SELL
$586.54 - $666.48 $954,300 - $1.08 Million
-1,627 Reduced 1.06%
152,380 $100 Million
Q3 2021

Nov 12, 2021

SELL
$621.9 - $705.76 $120,026 - $136,211
-193 Reduced 0.13%
154,007 $95.8 Million
Q2 2021

Aug 13, 2021

BUY
$486.36 - $637.08 $2.19 Million - $2.86 Million
4,494 Added 3.0%
154,200 $97.4 Million
Q1 2021

Apr 14, 2021

BUY
$465.18 - $551.79 $869,421 - $1.03 Million
1,869 Added 1.26%
149,706 $73.3 Million
Q4 2020

Jan 14, 2021

BUY
$383.85 - $499.87 $77,537 - $100,973
202 Added 0.14%
147,837 $73.9 Million
Q3 2020

Oct 15, 2020

SELL
$334.54 - $406.31 $39,141 - $47,538
-117 Reduced 0.08%
147,635 $58 Million
Q2 2020

Jul 30, 2020

SELL
$230.66 - $330.16 $143,931 - $206,019
-624 Reduced 0.42%
147,752 $48.8 Million
Q1 2020

Apr 15, 2020

BUY
$182.94 - $290.97 $334,231 - $531,602
1,827 Added 1.25%
148,376 $35.9 Million
Q4 2019

Jan 22, 2020

BUY
$248.66 - $285.01 $115,626 - $132,529
465 Added 0.32%
146,549 $38.3 Million
Q3 2019

Nov 05, 2019

SELL
$260.07 - $289.93 $218,718 - $243,831
-841 Reduced 0.57%
146,084 $39.7 Million
Q2 2019

Aug 09, 2019

SELL
$215.53 - $275.33 $66,814 - $85,352
-310 Reduced 0.21%
146,925 $40.5 Million
Q1 2019

Apr 08, 2019

BUY
$178.02 - $225.69 $282,161 - $357,718
1,585 Added 1.09%
147,235 $32.9 Million
Q4 2018

Feb 13, 2019

BUY
$176.18 - $248.92 $1.56 Million - $2.21 Million
8,873 Added 6.49%
145,650 $27.1 Million
Q3 2018

Oct 31, 2018

SELL
$218.82 - $254.46 $71,772 - $83,462
-328 Reduced 0.24%
136,777 $34.1 Million
Q2 2018

Aug 07, 2018

SELL
$185.56 - $227.9 $399,881 - $491,124
-2,155 Reduced 1.55%
137,105 $29.9 Million
Q1 2018

Apr 20, 2018

SELL
$157.81 - $204.73 $63,913 - $82,915
-405 Reduced 0.29%
139,260 $26.7 Million
Q4 2017

Feb 08, 2018

SELL
$147.68 - $168.37 $219,009 - $249,692
-1,483 Reduced 1.05%
139,665 $21.8 Million
Q3 2017

Oct 27, 2017

BUY
$150.32 - $166.46 $601 - $665
4 Added 0.0%
141,148 $21.9 Million
Q2 2017

Aug 07, 2017

BUY
N/A
141,144
141,144 $0

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $34.7B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.